Initiated Mkt Outperform X

ENOV Enovis Corporation

JMP Securities

$62

Initiated Neutral X

ENOV Enovis Corporation

JP Morgan

$53

Initiated Overweight X

ENOV Enovis Corporation

Stephens

$72

Initiated Buy X

ENOV Enovis Corporation

UBS

$75

Initiated Outperform X

ENOV Enovis Corporation

William Blair

Reiterated Buy X

ENOV Enovis Corporation

Needham

$62 $70

Initiated Buy X

ENOV Enovis Corporation

ROTH MKM

$75

Initiated Buy X

ENOV Enovis Corporation

Needham

$70

Upgrades Eq Weight Overweight X

ENOV Enovis Corporation

Wells Fargo

$55 $67

Initiated Buy X

ENOV Enovis Corporation

Jefferies

$60

Initiated Buy X

ENOV Enovis Corporation

Goldman

$57

Initiated Buy X

ENOV Enovis Corporation

Canaccord Genuity

$67

Initiated Outperform X

ENOV Enovis Corporation

Evercore ISI

$68

Initiated Hold X

ENOV Enovis Corporation

Argus

Resumed Buy X

ENOV Enovis Corporation

Loop Capital

$68

Initiated Equal Weight X

ENOV Enovis Corporation

Wells Fargo

$61

ENOV  Enovis Corporation

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.